iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/28630658
Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:4314025.
doi: 10.1155/2017/4314025. Epub 2017 May 29.

Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms

Affiliations
Review

Evidence of Mitochondrial Dysfunction in Autism: Biochemical Links, Genetic-Based Associations, and Non-Energy-Related Mechanisms

Keren K Griffiths et al. Oxid Med Cell Longev. 2017.

Abstract

Autism spectrum disorder (ASD), the fastest growing developmental disability in the United States, represents a group of neurodevelopmental disorders characterized by impaired social interaction and communication as well as restricted and repetitive behavior. The underlying cause of autism is unknown and therapy is currently limited to targeting behavioral abnormalities. Emerging studies suggest a link between mitochondrial dysfunction and ASD. Here, we review the evidence demonstrating this potential connection. We focus specifically on biochemical links, genetic-based associations, non-energy related mechanisms, and novel therapeutic strategies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between mitochondrial disease, ASD, and autism. Mitochondrial disease in most children with ASD is of the non-classical variety. Up to 5% of children with autism have classical mitochondrial disease while 10–20% of patients with classic mitochondrial disease demonstrate ASD features. The co-existence of ASD with mitochondrial disease is higher than the prevalence of either ASD or mitochondrial disease in the general population, suggesting a link between mitochondrial dysfunction and autism. Reprinted from [9].

Similar articles

Cited by

References

    1. Association, A.P. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013. pp. 50–59.
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--autism and developmental Disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002) 2012;61(3):1–19. - PubMed
    1. Blumberg S. J., Bramlett M. D., Kogan M. D., Schieve L. A., Jones J. R., Lu M. C. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. National Health Statistics Reports. 2013;65(65):1–11. - PubMed
    1. Wink L. K., Plawecki M. H., Erickson C. A., Stigler K. A., McDougle C. J. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opinion on Emerging Drugs. 2010;15(3):481–494. doi: 10.1517/14728214.2010.487860. - DOI - PMC - PubMed
    1. Currenti S. A. Understanding and determining the etiology of autism. Cellular and Molecular Neurobiology. 2010;30(2):161–171. doi: 10.1007/s10571-009-9453-8. - DOI - PubMed

MeSH terms